Allergan / Inamed / Natrelle

On December 18, 2018, Allergan Biocell implants were withdrawn from the market due to the increased risk of ALCL (cancer) >>

• McGhan BioDimensional Silicone-Filled Biocell Textured Breast Implants

• McGhan Magna-Site Tissue Expander

• McGhan Style 134 Croissant Shaped Tissue Expander

• Natrelle 133 Plus Issue Expanders

• Natrelle 133 Tissue Expanders with and without suture tabs

• Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants

• Natrelle Inspira Silicone-Filled Breast Implants

• Natrelle Saline Breast Implants

• Natrelle Silicone-Filled Breast Implants

• Style 133 Biospan Tissue Expander

Although Allergan / Natrelle 410 implants were approved in 2006, our organization received many reports of rupture and leakage from them. Some women reported ruptures within 2 and 3 years!

Directions for use Allergan >>

Safety and efficacy have not been established in patients with:

• Autoimmune diseases (such as lupus and scleroderma).

• A weakened immune system (for example, in immunosuppressive therapy).

• Conditions or medications that interfere with wound healing and blood clotting.

• Reduced blood supply to the breast tissue.

• Radiation therapy for breast cancer if you are wearing implants

• Clinical diagnosis of depression or other mental disorders, including body disorder and eating disorders.

Discuss any history of mental disorders prior to surgery.

Patients with a diagnosis of depression or other mental disorders, have to wait until resolution or stabilization

of these conditions to the undergoing breast implant surgery.

The FDA about complications of Allergan / Inamed implants . >>

Warranty >>

No new implants with symptoms >>